{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:33:21Z","timestamp":1769549601457,"version":"3.49.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ministry of Education and Science of Russia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transgenic Res"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11248-022-00325-7","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T05:02:53Z","timestamp":1661403773000},"page":"593-606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Studies on glycogen storage disease type 1a animal models: a brief perspective"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-3901","authenticated-orcid":false,"given":"Irina O.","family":"Petrova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1558-3048","authenticated-orcid":false,"given":"Svetlana A.","family":"Smirnikhina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"325_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.molmet.2014.05.005","volume":"3","author":"A Abdul-Wahed","year":"2014","unstructured":"Abdul-Wahed A, Gautier-Stein A, Casteras S et al (2014) A link between hepatic glucose production and peripheral energy metabolism via hepatokines. Mol Metab 3:531\u2013543. https:\/\/doi.org\/10.1016\/j.molmet.2014.05.005","journal-title":"Mol Metab"},{"key":"325_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/bjc.2013.765","volume":"110","author":"RE Airley","year":"2014","unstructured":"Airley RE, McHugh P, Evans AR et al (2014) Role of carbohydrate response element-binding protein (ChREBP) in generating an aerobic metabolic phenotype and in breast cancer progression. Br J Cancer 110:715\u2013723. https:\/\/doi.org\/10.1038\/bjc.2013.765","journal-title":"Br J Cancer"},{"key":"325_CR3","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/mt.2010.85","volume":"18","author":"A Akinc","year":"2010","unstructured":"Akinc A, Querbes W, De S et al (2010) Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol Ther 18:1357\u20131364. https:\/\/doi.org\/10.1038\/mt.2010.85","journal-title":"Mol Ther"},{"key":"325_CR4","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.ymthe.2020.12.027","volume":"29","author":"I Arnaoutova","year":"2021","unstructured":"Arnaoutova I, Zhang L, Chen HD et al (2021) Correction of metabolic abnormalities in a mouse model of glycogen storage disease type Ia by CRISPR\/Cas9-based gene editing. Mol Ther 29:1602\u20131610. https:\/\/doi.org\/10.1016\/j.ymthe.2020.12.027","journal-title":"Mol Ther"},{"key":"325_CR5","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/sj.gt.3301728","volume":"9","author":"RM Beaty","year":"2002","unstructured":"Beaty RM, Jackson M, Peterson D et al (2002) Delivery of glucose-6-phosphatase in a canine model for glycogen storage disease, type la, with adeno-associated virus (AAV) vectors. Gene Ther 9:1015\u20131022. https:\/\/doi.org\/10.1038\/sj.gt.3301728","journal-title":"Gene Ther"},{"key":"325_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/8904","volume":"18","author":"RD Beegle","year":"2015","unstructured":"Beegle RD, Brown LM, Weinstein DA (2015) Regression of hepatocellular adenomas with strict dietary therapy in patients with glycogen storage disease type I. JIMD Rep 18:23\u201332. https:\/\/doi.org\/10.1007\/8904","journal-title":"JIMD Rep"},{"key":"325_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF02072092","volume":"152","author":"L Bianchi","year":"1993","unstructured":"Bianchi L (1993) Glycogen storage disease I and hepatocellular tumours. Eur J Pediatr 152:63\u201370. https:\/\/doi.org\/10.1007\/BF02072092","journal-title":"Eur J Pediatr"},{"key":"325_CR8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1177\/030098589503200502","volume":"32","author":"AE Brix","year":"1995","unstructured":"Brix AE, Howerth EW, Egnor D et al (1995) Glycogen storage disease type Ia in two littermate maltese puppies. Vet Pathol 32:460\u2013465. https:\/\/doi.org\/10.1177\/030098589503200502","journal-title":"Vet Pathol"},{"key":"325_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ymgme.2013.03.018","volume":"109","author":"ED Brooks","year":"2013","unstructured":"Brooks ED, Little D, Arumugam R et al (2013) Pathogenesis of growth failure and partial reversal with gene therapy in murine and canine glycogen storage disease type Ia. Mol Genet Metab 109:161\u2013170. https:\/\/doi.org\/10.1016\/j.ymgme.2013.03.018","journal-title":"Mol Genet Metab"},{"key":"325_CR10","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s10545-018-0223-y","volume":"41","author":"ED Brooks","year":"2018","unstructured":"Brooks ED, Landau DJ, Everitt JI et al (2018) Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy. J Inherit Metab Dis 41:965\u2013976. https:\/\/doi.org\/10.1007\/s10545-018-0223-y","journal-title":"J Inherit Metab Dis"},{"key":"325_CR11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jhep.2012.09.030","volume":"58","author":"J Calderaro","year":"2013","unstructured":"Calderaro J, Labrune P, Morcrette G et al (2013) Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. J Hepatol 58:350\u2013357. https:\/\/doi.org\/10.1016\/j.jhep.2012.09.030","journal-title":"J Hepatol"},{"key":"325_CR12","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1021\/acs.jproteome.9b00309","volume":"18","author":"D Cangelosi","year":"2019","unstructured":"Cangelosi D, Resaz R, Petretto A et al (2019) A Proteomic analysis of GSD-1a in mouse livers: evidence for metabolic reprogramming, inflammation, and macrophage polarization. J Proteome Res 18:2965\u20132978. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00309","journal-title":"J Proteome Res"},{"key":"325_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-23318-2","volume":"12","author":"J Cao","year":"2021","unstructured":"Cao J, Choi M, Guadagnin E et al (2021) mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease. Nat Commun 12:1\u201314. https:\/\/doi.org\/10.1038\/s41467-021-23318-2","journal-title":"Nat Commun"},{"key":"325_CR14","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1007\/s00125-016-4097-y","volume":"59","author":"S Casteras","year":"2016","unstructured":"Casteras S, Abdul-Wahed A, Soty M et al (2016) The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice. Diabetologia 59:2645\u20132653. https:\/\/doi.org\/10.1007\/s00125-016-4097-y","journal-title":"Diabetologia"},{"key":"325_CR15","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1172\/JCI79213","volume":"125","author":"RJ Chandler","year":"2015","unstructured":"Chandler RJ, La Fave MC, Varshney GK et al (2015) Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy. J Clin Investig 125:870\u2013880. https:\/\/doi.org\/10.1172\/JCI79213","journal-title":"J Clin Investig"},{"key":"325_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1006819","volume":"13","author":"JH Cho","year":"2017","unstructured":"Cho JH, Kim GY, Pan CJ et al (2017) Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia. PLoS Genet 13:1\u201320. https:\/\/doi.org\/10.1371\/journal.pgen.1006819","journal-title":"PLoS Genet"},{"key":"325_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s10545-018-0192-1","volume":"41","author":"J Cho","year":"2018","unstructured":"Cho J, Kim G, Mansfield BC, Chou JY (2018) Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia. J Inherit Metab Dis 41:997\u20131006","journal-title":"J Inherit Metab Dis"},{"key":"325_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/jimd.12056","volume":"42","author":"JH Cho","year":"2019","unstructured":"Cho JH, Lee YM, Starost MF et al (2019) Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage. J Inherit Metab Dis 42:459\u2013469. https:\/\/doi.org\/10.1002\/jimd.12056","journal-title":"J Inherit Metab Dis"},{"key":"325_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2174\/1566524024605798","volume":"2","author":"J Chou","year":"2002","unstructured":"Chou J, Matern D, Mansfield B, Chen Y-T (2002) Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med 2:121\u2013143. https:\/\/doi.org\/10.2174\/1566524024605798","journal-title":"Curr Mol Med"},{"key":"325_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/ki.2014.102","volume":"86","author":"J Clar","year":"2014","unstructured":"Clar J, Gri B, Calderaro J et al (2014) Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy. Kidney Int 86:747\u2013756. https:\/\/doi.org\/10.1038\/ki.2014.102","journal-title":"Kidney Int"},{"key":"325_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/pedi.12540","volume":"18","author":"M Dambska","year":"2017","unstructured":"Dambska M, Labrador EB, Kuo CL, Weinstein DA (2017) Prevention of complications in glycogen storage disease type Ia with optimization of metabolic control. Pediatr Diabetes 18:327\u2013331. https:\/\/doi.org\/10.1111\/pedi.12540","journal-title":"Pediatr Diabetes"},{"key":"325_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/ckj\/sfs143","volume":"5","author":"J Dick","year":"2012","unstructured":"Dick J, Kumar N, Horsfield C, Jayawardene S (2012) AA Amyloidosis in a patient with glycogen storage disorder and progressive chronic kidney disease. Clin Kidney J 5:559\u2013561. https:\/\/doi.org\/10.1093\/ckj\/sfs143","journal-title":"Clin Kidney J"},{"key":"325_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2015.10.008","volume":"64","author":"BL Farah","year":"2016","unstructured":"Farah BL, Landau DJ, Sinha RA et al (2016) Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency. J Hepatol 64:370\u2013379. https:\/\/doi.org\/10.1016\/j.jhep.2015.10.008","journal-title":"J Hepatol"},{"key":"325_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep44408","volume":"7","author":"BL Farah","year":"2017","unstructured":"Farah BL, Sinha RA, Wu Y et al (2017) Hepatic mitochondrial dysfunction is a feature of glycogen storage disease type Ia (GSDIa). Sci Rep 7:1\u201312. https:\/\/doi.org\/10.1038\/srep44408","journal-title":"Sci Rep"},{"key":"325_CR25","doi-asserted-by":"publisher","first-page":"10887","DOI":"10.1073\/pnas.93.20.10887","volume":"93","author":"R Feil","year":"1996","unstructured":"Feil R, Brocard J, Mascrez B et al (1996) Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci U S A 93:10887\u201310890. https:\/\/doi.org\/10.1073\/pnas.93.20.10887","journal-title":"Proc Natl Acad Sci U S A"},{"key":"325_CR26","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.cell.2014.11.006","volume":"159","author":"L Galluzzi","year":"2014","unstructured":"Galluzzi L, Pietrocola F, Levine B, Kroemer G (2014) Metabolic control of autophagy. Cell 159:1263\u20131276. https:\/\/doi.org\/10.1016\/j.cell.2014.11.006","journal-title":"Cell"},{"key":"325_CR27","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/hmg\/ddaa007","volume":"29","author":"S Gautam","year":"2020","unstructured":"Gautam S, Zhang L, Arnaoutova I et al (2020) The signaling pathways implicated in impairment of hepatic autophagy in glycogen storage disease type Ia. Hum Mol Genet 29:834\u2013844","journal-title":"Hum Mol Genet"},{"key":"325_CR28","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1093\/hmg\/ddw224","volume":"25","author":"M Gjorgjieva","year":"2016","unstructured":"Gjorgjieva M, Raffin M, Duchampt A et al (2016) Progressive development of renal cysts in glycogen storage disease type I. Hum Mol Genet 25:3784\u20133797. https:\/\/doi.org\/10.1093\/hmg\/ddw224","journal-title":"Hum Mol Genet"},{"key":"325_CR29","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jhep.2018.07.017","volume":"69","author":"M Gjorgjieva","year":"2018","unstructured":"Gjorgjieva M, Calderaro J, Monteillet L et al (2018) Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia. J Hepatol 69:1074\u20131087. https:\/\/doi.org\/10.1016\/j.jhep.2018.07.017","journal-title":"J Hepatol"},{"key":"325_CR30","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1126\/science.1201940","volume":"333","author":"DR Green","year":"2011","unstructured":"Green DR, Galluzzi L, Kroemer G (2011) Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science (80-) 333:1109\u20131112. https:\/\/doi.org\/10.1126\/science.1201940","journal-title":"Science (80-)"},{"key":"325_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/nejm197602192940805","volume":"294","author":"HL Greene","year":"1976","unstructured":"Greene HL, Slonim AE, O\u2019Neill JA, Burr IM (1976) Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease. N Engl J Med 294:423\u2013425. https:\/\/doi.org\/10.1056\/nejm197602192940805","journal-title":"N Engl J Med"},{"key":"325_CR32","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1161\/CIRCRESAHA.110.227371","volume":"107","author":"N Hariharan","year":"2010","unstructured":"Hariharan N, Maejima Y, Nakae J et al (2010) Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes. Circ Res 107:1470\u20131482. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.227371","journal-title":"Circ Res"},{"key":"325_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jimd.12380","volume":"44","author":"JA Hoogerland","year":"2021","unstructured":"Hoogerland JA, Peeks F, Hijmans BS et al (2021) Impaired very-low-density lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in glycogen storage disease type Ia. J Inherit Metab Dis 44:1\u201314. https:\/\/doi.org\/10.1002\/jimd.12380","journal-title":"J Inherit Metab Dis"},{"key":"325_CR34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.omtm.2019.10.016","volume":"15","author":"HR Kang","year":"2019","unstructured":"Kang HR, Gjorgjieva M, Smith SN et al (2019a) Pathogenesis of hepatic tumors following gene therapy in murine and canine models of glycogen storage disease. Mol Ther Methods Clin Dev 15:383\u2013391. https:\/\/doi.org\/10.1016\/j.omtm.2019.10.016","journal-title":"Mol Ther Methods Clin Dev"},{"key":"325_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.omtm.2019.02.002","volume":"13","author":"HR Kang","year":"2019","unstructured":"Kang HR, Waskowicz L, Seifts AM et al (2019b) Bezafibrate enhances AAV vector-mediated genome editing in glycogen storage disease type Ia. Mol Ther Methods Clin Dev 13:265\u2013273. https:\/\/doi.org\/10.1016\/j.omtm.2019.02.002","journal-title":"Mol Ther Methods Clin Dev"},{"key":"325_CR36","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1016\/j.febslet.2007.07.013","volume":"581","author":"SY Kim","year":"2007","unstructured":"Kim SY, Chen LY, Yiu WH et al (2007) Neutrophilia and elevated serum cytokines are implicated in glycogen storage disease type Ia. FEBS Lett 581:3833\u20133838. https:\/\/doi.org\/10.1016\/j.febslet.2007.07.013","journal-title":"FEBS Lett"},{"key":"325_CR37","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jhep.2007.11.014","volume":"48","author":"SY Kim","year":"2008","unstructured":"Kim SY, Weinstein DA, Starost MF et al (2008) Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia. J Hepatol 48:479\u2013485. https:\/\/doi.org\/10.1016\/j.jhep.2007.11.014","journal-title":"J Hepatol"},{"key":"325_CR38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ymgme.2017.01.003","volume":"120","author":"G Kim","year":"2017","unstructured":"Kim G, Lee YM, Kwon JH et al (2017) Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-\u03b1 activity restored are at risk of developing hepatic tumors. Mol Genet Metab 120:229\u2013234. https:\/\/doi.org\/10.1016\/j.ymgme.2017.01.003","journal-title":"Mol Genet Metab"},{"key":"325_CR39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1006\/bmme.1997.2600","volume":"61","author":"PS Kishnani","year":"1997","unstructured":"Kishnani PS, Bao Y, Wu JY et al (1997) Isolation and nucleotide sequence of canine glucose-6-phosphatase mRNA: Identification of mutation in puppies with glycogen storage disease type Ia. Biochem Mol Med 61:168\u2013177. https:\/\/doi.org\/10.1006\/bmme.1997.2600","journal-title":"Biochem Mol Med"},{"key":"325_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1354\/vp.38-1-83","volume":"38","author":"PS Kishnani","year":"2001","unstructured":"Kishnani PS, Faulkner E, VanCamp S et al (2001) Canine model and genomic structural organization of glycogen storage disease type Ia (GSD Ia). Vet Pathol 38:83\u201391. https:\/\/doi.org\/10.1354\/vp.38-1-83","journal-title":"Vet Pathol"},{"key":"325_CR41","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/sj.gt.3302774","volume":"13","author":"DD Koeberl","year":"2006","unstructured":"Koeberl DD, Sun BD, Damodaran TV et al (2006) Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia. Gene Ther 13:1281\u20131289. https:\/\/doi.org\/10.1038\/sj.gt.3302774","journal-title":"Gene Ther"},{"key":"325_CR42","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/mt.2008.15","volume":"16","author":"DD Koeberl","year":"2008","unstructured":"Koeberl DD, Pinto C, Sun B et al (2008) AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia. Mol Ther 16:665\u2013672. https:\/\/doi.org\/10.1038\/mt.2008.15","journal-title":"Mol Ther"},{"key":"325_CR43","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/mt.2016.35","volume":"24","author":"DJ Landau","year":"2016","unstructured":"Landau DJ, Brooks ED, Perez-Pinera P et al (2016) In vivo zinc finger nuclease-mediated targeted integration of a glucose-6-phosphatase transgene promotes survival in mice with glycogen storage disease type IA. Mol Ther 24:697\u2013706. https:\/\/doi.org\/10.1038\/mt.2016.35","journal-title":"Mol Ther"},{"key":"325_CR44","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/hep.25717","volume":"56","author":"YM Lee","year":"2012","unstructured":"Lee YM, Jun HS, Pan CJ et al (2012) Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy. Hepatology 56:1719\u20131729. https:\/\/doi.org\/10.1002\/hep.25717","journal-title":"Hepatology"},{"key":"325_CR45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature13961","volume":"516","author":"JM Lee","year":"2014","unstructured":"Lee JM, Wagner M, Xiao R et al (2014) Nutrient sensing nuclear receptors coordinate autophagy. Nature 516:112\u2013115. https:\/\/doi.org\/10.1038\/nature13961","journal-title":"Nature"},{"key":"325_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ymgmr.2015.03.001","volume":"3","author":"YM Lee","year":"2015","unstructured":"Lee YM, Kim GY, Pan CJ et al (2015) Minimal hepatic glucose-6-phosphatase-\u03b1 activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia. Mol Genet Metab Rep 3:28\u201332. https:\/\/doi.org\/10.1016\/j.ymgmr.2015.03.001","journal-title":"Mol Genet Metab Rep"},{"key":"325_CR47","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s10545-018-0248-2","volume":"41","author":"YM Lee","year":"2018","unstructured":"Lee YM, Conlon TJ, Specht A et al (2018) Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia. J Inherit Metab Dis 41:977\u2013984. https:\/\/doi.org\/10.1007\/s10545-018-0248-2","journal-title":"J Inherit Metab Dis"},{"key":"325_CR48","first-page":"766","volume":"57","author":"KJ Lei","year":"1995","unstructured":"Lei KJ, Chen YT, Chen H et al (1995) Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus. Am J Hum Genet 57:766\u2013771","journal-title":"Am J Hum Genet"},{"key":"325_CR49","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/ng0696-203","volume":"13","author":"KJ Lei","year":"1996","unstructured":"Lei KJ, Chen H, Pan CJ et al (1996) Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse. Nat Genet 13:203\u2013209. https:\/\/doi.org\/10.1038\/ng0696-203","journal-title":"Nat Genet"},{"key":"325_CR50","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/hep.31198","volume":"72","author":"Y Lei","year":"2020","unstructured":"Lei Y, Hoogerland JA, Bloks VW et al (2020) Hepatic carbohydrate response element binding protein activation limits nonalcoholic fatty liver disease development in a mouse model for glycogen storage disease type 1a. Hepatology 72:1638\u20131653. https:\/\/doi.org\/10.1002\/hep.31198","journal-title":"Hepatology"},{"key":"325_CR51","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1038\/mt.2011.126","volume":"19","author":"X Luo","year":"2011","unstructured":"Luo X, Hall G, Li S et al (2011) Hepatorenal correction in murine glycogen storage disease type i with a double-stranded adeno-associated virus vector. Mol Ther 19:1961\u20131970. https:\/\/doi.org\/10.1038\/mt.2011.126","journal-title":"Mol Ther"},{"key":"325_CR52","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ncb2329","volume":"13","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova MM, Shaw RJ (2011) The AMP-activated protein kinase (AMPK) signaling pathway coordinates cell growth, autophagy, and metabolism. Nat Cell Biol 13:1016\u20131023. https:\/\/doi.org\/10.1038\/ncb2329","journal-title":"Nat Cell Biol"},{"key":"325_CR53","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.molmet.2018.07.006","volume":"16","author":"L Monteillet","year":"2018","unstructured":"Monteillet L, Gjorgjieva M, Silva M et al (2018) Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context. Mol Metab 16:100\u2013115. https:\/\/doi.org\/10.1016\/j.molmet.2018.07.006","journal-title":"Mol Metab"},{"key":"325_CR54","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/hmg\/ddab297","volume":"31","author":"L Monteillet","year":"2022","unstructured":"Monteillet L, Labrune P, Hochuli M et al (2022) Cellular and metabolic effects of renin-angiotensin system blockade on glycogen storage disease type I nephropathy. Hum Mol Genet 31:914\u2013928. https:\/\/doi.org\/10.1093\/hmg\/ddab297","journal-title":"Hum Mol Genet"},{"key":"325_CR55","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1046\/j.1365-2265.2003.01717.x","volume":"58","author":"HR Mundy","year":"2003","unstructured":"Mundy HR, Hindmarsh PC, Matthews DR et al (2003) The regulation of growth in glycogen storage disease type 1. Clin Endocrinol (oxf) 58:332\u2013339. https:\/\/doi.org\/10.1046\/j.1365-2265.2003.01717.x","journal-title":"Clin Endocrinol (oxf)"},{"key":"325_CR56","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jhep.2010.08.014","volume":"54","author":"E Mutel","year":"2011","unstructured":"Mutel E, Abdul-Wahed A, Ramamonjisoa N et al (2011a) Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas. J Hepatol 54:529\u2013537. https:\/\/doi.org\/10.1016\/j.jhep.2010.08.014","journal-title":"J Hepatol"},{"key":"325_CR57","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.2337\/db11-0571","volume":"60","author":"E Mutel","year":"2011","unstructured":"Mutel E, Gautier-Stein A, Abdul-Wahed A et al (2011b) Control of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice: induction of renal and intestinal gluconeogenesis by glucagon. Diabetes 60:3121\u20133131. https:\/\/doi.org\/10.2337\/db11-0571","journal-title":"Diabetes"},{"key":"325_CR58","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ng.3389","volume":"47","author":"JC Nault","year":"2015","unstructured":"Nault JC, Datta S, Imbeaud S et al (2015) Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat Genet 47:1187\u20131193. https:\/\/doi.org\/10.1038\/ng.3389","journal-title":"Nat Genet"},{"key":"325_CR59","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1002\/jcp.24399","volume":"228","author":"F Ng","year":"2013","unstructured":"Ng F, Tang BL (2013) Sirtuins\u2019 modulation of autophagy. J Cell Physiol 228:2262\u20132270. https:\/\/doi.org\/10.1002\/jcp.24399","journal-title":"J Cell Physiol"},{"key":"325_CR60","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/dvg.20538","volume":"47","author":"WT Peng","year":"2009","unstructured":"Peng WT, Pan CJ, Lee EJ et al (2009) Generation of mice with a conditional allele for G6pc. Genesis 47:590\u2013594. https:\/\/doi.org\/10.1002\/dvg.20538","journal-title":"Genesis"},{"key":"325_CR61","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.physbeh.2011.03.012","volume":"105","author":"A Penhoat","year":"2011","unstructured":"Penhoat A, Mutel E, Amigo-Correig M et al (2011) Protein-induced satiety is abolished in the absence of intestinal gluconeogenesis. Physiol Behav 105:89\u201393. https:\/\/doi.org\/10.1016\/j.physbeh.2011.03.012","journal-title":"Physiol Behav"},{"key":"325_CR62","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00000478-198806000-00008","volume":"12","author":"R Poe","year":"1988","unstructured":"Poe R, Snover DC (1988) Adenomas in glycogen storage disease type 1 two cases with unusual histologic features. Am J Surg Pathol 12:477\u2013483","journal-title":"Am J Surg Pathol"},{"key":"325_CR63","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10545-014-9761-0","volume":"38","author":"F Rajas","year":"2015","unstructured":"Rajas F, Clar J, Gautier-Stein A, Mithieux G (2015) Lessons from new mouse models of glycogen storage disease type 1a in relation to the time course and organ specificity of the disease. J Inherit Metab Dis 38:521\u2013527. https:\/\/doi.org\/10.1007\/s10545-014-9761-0","journal-title":"J Inherit Metab Dis"},{"key":"325_CR64","doi-asserted-by":"publisher","first-page":"101108","DOI":"10.1016\/j.molmet.2020.101108","volume":"43","author":"F Rajas","year":"2021","unstructured":"Rajas F, Dentin R, Cannella Miliano A et al (2021) The absence of hepatic glucose-6 phosphatase\/ChREBP couple is incompatible with survival in mice. Mol Metab 43:101108. https:\/\/doi.org\/10.1016\/j.molmet.2020.101108","journal-title":"Mol Metab"},{"key":"325_CR65","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1007\/s00431-002-0999-4","volume":"161","author":"J Rake","year":"2002","unstructured":"Rake J, Visser G, Labrune P et al (2002) Glycogen storage disease type I: diagnosis, management, clinical course and outcome. results of the European study on glycogen storage disease type I (ESGSD I). Eur J Pediatr 161:S20\u2013S34. https:\/\/doi.org\/10.1007\/s00431-002-0999-4","journal-title":"Eur J Pediatr"},{"key":"325_CR66","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1242\/dmm.014878","volume":"7","author":"R Resaz","year":"2014","unstructured":"Resaz R, Vanni C, Segalerba D et al (2014) Development of hepatocellular adenomas and carcinomas in mice with liver-specific G6Pase-a\u03b1 deficiency. DMM Dis Model Mech 7:1083\u20131091. https:\/\/doi.org\/10.1242\/dmm.014878","journal-title":"DMM Dis Model Mech"},{"key":"325_CR67","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.ymthe.2018.01.006","volume":"26","author":"DS Roseman","year":"2018","unstructured":"Roseman DS, Khan T, Rajas F et al (2018) G6PC mRNA therapy positively regulates fasting blood glucose and decreases liver abnormalities in a mouse model of glycogen storage disease 1a. Mol Ther 26:814\u2013821. https:\/\/doi.org\/10.1016\/j.ymthe.2018.01.006","journal-title":"Mol Ther"},{"key":"325_CR68","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1002\/hep.32022","volume":"74","author":"MGS Rutten","year":"2021","unstructured":"Rutten MGS, Derks TGJ, Huijkman NCA et al (2021) Modeling phenotypic heterogeneity of glycogen storage disease type 1a liver disease in mice by somatic CRISPR\/CRISPR-associated protein 9\u2013mediated gene editing. Hepatology 74:2491\u20132507. https:\/\/doi.org\/10.1002\/hep.32022","journal-title":"Hepatology"},{"key":"325_CR69","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/hmg\/ddz283","volume":"29","author":"A Saeed","year":"2020","unstructured":"Saeed A, Hoogerland JA, Wessel H et al (2020) Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels. Hum Mol Genet 29:264\u2013273. https:\/\/doi.org\/10.1093\/hmg\/ddz283","journal-title":"Hum Mol Genet"},{"key":"325_CR70","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1093\/hmg\/11.18.2155","volume":"11","author":"MS Sun","year":"2002","unstructured":"Sun MS, Pan CJ, Shieh JJ et al (2002) Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice. Hum Mol Genet 11:2155\u20132164. https:\/\/doi.org\/10.1093\/hmg\/11.18.2155","journal-title":"Hum Mol Genet"},{"key":"325_CR71","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/jhn.12030","volume":"26","author":"KK Shah","year":"2013","unstructured":"Shah KK, O\u2019Dell SD (2013) Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis. J Hum Nutr Diet 26:329\u2013339. https:\/\/doi.org\/10.1111\/jhn.12030","journal-title":"J Hum Nutr Diet"},{"key":"325_CR72","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1477-2574.2010.00222.x","volume":"12","author":"JHMB Stoot","year":"2010","unstructured":"Stoot JHMB, Coelen RJS, De Jong MC, Dejong CHC (2010) Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB 12:509\u2013522. https:\/\/doi.org\/10.1111\/j.1477-2574.2010.00222.x","journal-title":"HPB"},{"key":"325_CR73","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1242\/dmm.014878","volume":"362","author":"E van Schaftingen","year":"2002","unstructured":"van Schaftingen E, Gerin I (2002) The glucose-6-phosphatase system. Biochem J 362:513\u2013532. https:\/\/doi.org\/10.1242\/dmm.014878","journal-title":"Biochem J"},{"key":"325_CR74","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/hmg\/ddy343","volume":"28","author":"LR Waskowicz","year":"2019","unstructured":"Waskowicz LR, Zhou J, Landau DL et al (2019) Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia. Hum Mol Genet 28:143\u2013154","journal-title":"Hum Mol Genet"},{"key":"325_CR75","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1089\/hum.2009.157","volume":"21","author":"DA Weinstein","year":"2010","unstructured":"Weinstein DA, Correia CE, Conlon T et al (2010) Adeno-associated virus-mediated correction of a canine model of glycogen storage disease type Ia. Hum Gene Ther 21:903\u2013910. https:\/\/doi.org\/10.1089\/hum.2009.157","journal-title":"Hum Gene Ther"},{"key":"325_CR76","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/hmg\/ddz290","volume":"29","author":"ZA Yavarow","year":"2020","unstructured":"Yavarow ZA, Kang H-R, Waskowicz LR et al (2020) Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia. Hum Mol Genet 29:286\u2013294","journal-title":"Hum Mol Genet"},{"key":"325_CR77","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/sj.ki.5002718","volume":"7323","author":"WH Yiu","year":"2008","unstructured":"Yiu WH, Pan C-J, Ruef RA et al (2008) The angiotensin system mediates renal fibrosis in glycogen storage disease type Ia nephropathy. Kidney Int 7323:716\u2013723","journal-title":"Kidney Int"},{"key":"325_CR78","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/mt.2010.64","volume":"18","author":"WH Yiu","year":"2010","unstructured":"Yiu WH, Lee YM, Peng WT et al (2010a) Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy. Mol Ther 18:1076\u20131084. https:\/\/doi.org\/10.1038\/mt.2010.64","journal-title":"Mol Ther"},{"key":"325_CR79","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/labinvest.2010.38","volume":"90","author":"WH Yiu","year":"2010","unstructured":"Yiu WH, Mead PA, Jun HS et al (2010b) Oxidative stress mediates nephropathy in type Ia glycogen storage disease. Lab Investig 90:620\u2013629. https:\/\/doi.org\/10.1038\/labinvest.2010.38","journal-title":"Lab Investig"},{"key":"325_CR80","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.bbrc.2020.04.124","volume":"527","author":"L Zhang","year":"2020","unstructured":"Zhang L, Lee C, Arnaoutova I et al (2020) Gene therapy using a novel G6PC-S298C variant enhances the long-term efficacy for treating glycogen storage disease type Ia. Biochem Biophys Res Commun 527:824\u2013830. https:\/\/doi.org\/10.1016\/j.bbrc.2020.04.124","journal-title":"Biochem Biophys Res Commun"},{"key":"325_CR81","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1089\/thy.2019.0007","volume":"29","author":"J Zhou","year":"2019","unstructured":"Zhou J, Waskowicz LR, Lim A et al (2019) A liver-specific thyromimetic, VK2809, decreases hepatosteatosis in glycogen storage disease type Ia. Thyroid 29:1158\u20131167. https:\/\/doi.org\/10.1089\/thy.2019.0007","journal-title":"Thyroid"}],"container-title":["Transgenic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11248-022-00325-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11248-022-00325-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11248-022-00325-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T09:17:58Z","timestamp":1670923078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11248-022-00325-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1007\/s11248-022-00325-7","relation":{},"ISSN":["0962-8819","1573-9368"],"issn-type":[{"value":"0962-8819","type":"print"},{"value":"1573-9368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"assertion":[{"value":"25 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}